Funds injection for drug delivery pioneer

A drug delivery specialist has received a £2 million funding injection including investment from Archangels, the Edinburgh-based business angel syndicate.

Bio-images Drug Delivery (BDD), which has operations in Glasgow and Newhouse, said the funds would enable it to scale its business, focusing on its precision timed drug delivery system – Oralogik.

The technology enables the oral delivery of single, multidose or combination drugs at pre-determined times between one and 12 hours after being swallowed by the patient.

BDD will invest in processing and analytical equipment for the large-scale manufacture of the system. Carol Thomson, the firm’s chief executive, said: “Oralogik is a truly exciting technology that could transform the lives of many patients and this funding will accelerate its route to market.

“More than that, by partnering with Archangels, BDD can access its network of sector experts and ensure that we can fully capitalise on the potential of Oralogik.”

Sarah Hardy, investment director at Archangels, said: “We are confident that Oralogik could become a game changer for drugs that will be more effective with delayed or phased delivery.”

Kerry Sharp, director of the Scottish Investment Bank, which is also involved in the funding round, added: “We’ve supported the company through our financial readiness and account management approach and we look forward to continuing this to help deliver its growth plans.” 0 Carol Thomson – looking to scale up the business